DIREVO INDUSTRIAL BIOTECHNOLOGY
DIREVO provides customized solutions for various industries via the development and optimization of biocatalysts with its proprietary ultra-high-throughput screening platform. Serving the Feed & Food industries and chemical / biorefinery businesses, DIREVO products are developed either independently or in conjunction with global leaders such as Genencor (a division of Danisco A/S), AB Enzymes, Roal Ltd. and Nestlé. DIREVO Industrial Biotechnology GmbH is privately owned and located in Cologne... , Germany. The shareholders include Wölbern EquityPartner GmbH (Hamburg), NRW Bank (Düsseldorf), TVM Capital (Munich), Danisco A/S (Copenhagen), a private equity firm affiliated with Sparkasse KölnBonn (Cologne), SandersMorrisHarris EnzymesLLC (New York), Mulligan BioCapital (Hamburg), and several private investors.
DIREVO INDUSTRIAL BIOTECHNOLOGY
Social Links:
Industry:
Biomass Energy Biotechnology Industrial
Founded:
2000-01-01
Address:
Cologne, Nordrhein-Westfalen, Germany
Country:
Germany
Website Url:
http://www.direvo.com
Total Employee:
11+
Status:
Closed
Contact:
49 221-47448-0
Email Addresses:
[email protected]
Total Funding:
51.57 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics
Current Employees Featured
Investors List
TVM Capital
TVM Capital investment in Series D - DIREVO Industrial Biotechnology
NRW.BANK
NRW.BANK investment in Series D - DIREVO Industrial Biotechnology
TVM Capital
TVM Capital investment in Venture Round - DIREVO Industrial Biotechnology
NRW.BANK
NRW.BANK investment in Venture Round - DIREVO Industrial Biotechnology
TVM Capital
TVM Capital investment in Series C - DIREVO Industrial Biotechnology
S-Equity Partner
S-Equity Partner investment in Series C - DIREVO Industrial Biotechnology
Bankhaus Wölbern
Bankhaus Wölbern investment in Series C - DIREVO Industrial Biotechnology
Mulligan BioCapital
Mulligan BioCapital investment in Series C - DIREVO Industrial Biotechnology
NRW.BANK
NRW.BANK investment in Series C - DIREVO Industrial Biotechnology
Signet Healthcare Partners
Signet Healthcare Partners investment in Series C - DIREVO Industrial Biotechnology
Official Site Inspections
http://www.direvo.com
- Host name: 154.3.129.113
- IP address: 154.3.129.113
- Location: London United Kingdom
- Latitude: 51.5164
- Longitude: -0.093
- Timezone: Europe/London
- Postal: EC2V
